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Abstract
Background: Utilization of estrus synchronization program in livestock industry would provide greater options for
reproductive management in herd. To develop a convenient method for estrus synchronization in pigs, we
determined the effective protocol using estradiol dipropionate (EDP) for the establishment of pseudopregnancy
and investigated follicular development during the estrus synchronization with prostaglandin F2alpha (PGF2alpha)
in association with reproductive hormone profiles in pseudopregnant sows.
Methods: In Experiment 1, the effective dose (0, 10, 20, or 30 mg) and timing (5, 8, 11 or 13 days after ovulation)
of a single administration of EDP in cyclic pigs for the induction of pseudopregnancy were investigated. In
Experiment 2, four pseudopregnant sows were treated with PGF2alpha twice at a 24-h interval between 24 and 28
days after EDP treatment. The changes in plasma concentrations of reproductive hormones were analyzed by time-
resolved fluoroimmunoassay. Follicular development and ovulation following PGF2alpha administration were
monitored by transrectal ultrasonography.
Results: High efficiency (greater than 80%) of pseudopregnancy was achieved with a single treatment with 20 mg
of EDP at 8 and 11 days after ovulation (equivalent to 9-13 days after the onset of estrus). Plasma estradiol-17beta
concentrations in pseudopregnant sows were significantly higher between 12 h and 7 days than before EDP
treatment. Total inhibin concentrations significantly decreased following EDP treatment and remained low for 14
days. The number of small follicles was increased from 6.3 +/- 2.6 at PGF2alpha treatment to 22.8 +/- 4.8 at 3 days
later; this was associated with increased plasma concentrations of inhibin. Onset of estrus was detectable in all
sows on 5.3 +/- 0.3 days after PGF2alpha treatment and the number of ovulated follicles was 15.5 +/- 1.4 detected
at 7.6 +/- 0.2 days after the treatment.
Conclusions: This study has defined the effective dose and timing of EDP treatment for inducing
pseudopregnancy in cyclic pigs. Our results also indicated that EDP caused a lowering of inhibin concentrations
during pseudopregnancy and small numbers of follicles from 20 to 28 days after EDP. In contrast, EDP-induced
pseudopregnancy appears to have no adverse effect on follicular development and subsequent ovulation following
PGF2alpha administration.
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Background
In pigs, estrogen stimulation from the conceptus plays a
role in maternal recognition of the conceptus for the
establishment of pregnancy [1]. Repeated treatment with
estradiol benzoate (EB) [2] or estradiol valerate (EV) [3]
can extend the luteal function in cyclic pigs as a substi-
tute for the signals from the conceptus, resulting in pseu-
dopregnancy. Because pseudopregnant pigs exhibit estrus
within a given period after prostaglandin F2a (PGF2a)
administration [2-4], this protocol is applicable for estrus
synchronization. However, the traditional procedure
requires considerable effort and cost for inducing pseu-
dopregnancy by multiple administrations of EB or EV.
Estradiol dipropionate (EDP), which is a human phar-
maceutical, exhibited prolonged estradiol-17b effects
compared with EB and EV in rats [5] and humans [6].
Our previous study showed that a single administration
of EDP at 12 days after the onset of estrus could also
induce pseudopregnancy in gilts and plasma estradiol-
17b concentrations in pseudopregnant gilts were main-
tained at high levels for 9 days after EDP treatment [4].
However, the optimum dose and timing of EDP treat-
ment to induce pseudopregnancy in pigs has not yet
been determined.
Although EB delayed new follicular wave emergence
after follicular aspiration in cattle [7], the effect of high
concentrations of estradiol-17b on follicular develop-
ment in pigs is not clear. The analysis of follicular
dynamics during treatments is important for develop-
ment of an effective estrus synchronization protocol.
The developmental stage of follicles at the time of
induced luteolysis with PGF2a affected the interval from
treatment to ovulation in cattle [8]. In previous reports,
83% to 100% of pseudopregnant pigs induced by EB
[2,9] or EDP [4] exhibited estrus after PGF2a treatment
[2,4,9], while the interval from the treatment to estrus
ranged from 4 to 7 days [2-4,9]. To explain this varia-
tion, morphometric analysis of not only changes in cor-
pora lutea (CL), but also in follicular development
before and after PGF2a treatment, was required.
Inhibin levels in the circulation are recognized to
reflect the number of antral follicles present on ovaries in
cows [10], goats [11], and pigs [12]. Since the profiles of
inhibin A and total inhibin during the porcine estrous
cycle clearly corresponded with changes in the number
of follicles more than 3 mm in diameter detected by
ultrasonography [12], measurement of inhibin concentra-
tions in plasma may be useful for understanding the
alteration of follicular dynamics in pseudopregnant pigs.
Moreover, exogenous estrogen affects the kinetics of var-
ious reproductive hormones, such as suppression of
gonadotropin-releasing hormone secretion in the
hypothalamus [13] and decreases of follicle-stimulating
hormone (FSH) and luteinizing hormone (LH) concen-
trations in peripheral blood [13-15]. Furthermore, secre-
tory patterns of LH, prolactin and progesterone during
pseudopregnancy do not imitate the implantation period
of natural pregnancy in the pig [16]. Thus, comprehen-
sive analysis of reproductive hormones, including inhibin,
estradiol-17b, progesterone, LH, and FSH, in pseudo-
pregnant pigs should be helpful to establish the porcine
estrus synchronization protocol using EDP and PGF2a.
The aims of the present study were: (1) to determine
the effective dose and timing of EDP administration in
cyclic pigs for the induction of pseudopregnancy and the
profiles of inhibin and other reproductive hormones in
pseudopregnant pigs induced by EDP treatment, and (2)
to investigate the relationship between the profiles of
reproductive hormones and the changes in ovarian struc-
tures after PGF2a treatment in pseudopregnant sows.
Methods
Animals and treatments
All animal-related procedures employed in this study
were approved by the Institutional Care and Use Com-
mittee for Laboratory Animals of the National Institute
of Animal Health. This experiment was carried out at
the National Institute of Animal Health in Tsukuba,
Japan. Five mature cyclic gilts that exhibited more than
nine estrous cycles after puberty (Landrace [L] × Large
White [W]; 20.2 ± 1.1 [mean ± SEM] months, 180 ±
13.8 kg) and 35 sows (L, n = 6; W, n = 2; and LW, n =
27; 27.9 ± 2.9 months, 201.0 ± 5.1 kg, 2.4 ± 0.5 parities)
were used. Estrus was checked twice daily using a
mature boar by the method previously described [12].
All sows were in estrus within 10 days after weaning
and exhibited one or more estrous cycles (averaged on
4.2 ± 0.5). At least one estrous cycle of normal length
(18-24 days) was observed in each pig immediately
before the start of the study.
Treatments and experimental design
Experiment 1
In the first part of experiment 1, to determine the
dosage of EDP (Ovahormone Depot; ASKA Pharmaceu-
tical Co., Ltd., Tokyo, Japan) required to establish pseu-
dopregnancy, animals were given 0 (vehicle of 20% [vol/
vol] benzyl benzoate in sesame oil, n = 4), 10 (n = 4),
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once at either 10-13 days after the onset of estrus. In
the second part of experiment 1, sows were treated with
20 mg of EDP at 5 (n = 5), 8 (n = 5), 11 (n = 4), or 13
days (n = 5) after ovulation to examine precisely the
effect of timing of EDP treatment on the induction of
pseudopregnancy. Five, 8, 11 and 13 days after ovulation
were equivalent to 6-7, 9-10, 12-13 and 14-16 days after
the onset of estrus, respectively. Ovulation was detected
using transrectal ultrasonography in all sows as pre-
viously described [17]. Animals were checked for estrus
from 17 days after the onset of estrus until the end of
the subsequent estrus was observed, or until 24 days
after treatment if they did not exhibit a subsequent
estrus. Each animal was fitted with an indwelling cathe-
ter in the auricular vein at least 3 days before each
treatment. Blood samples were collected at least daily
from the day of catheterization until 10 days after the
onset of the subsequent estrus, or until 24 days after the
treatment if estrus was not observed. Plasma was recov-
ered after centrifugation of blood and stored at -20°C.
Pseudopregnancy was defined as the absence of estrus
with plasma progesterone concentrations of more than
5 ng/mL, maintained until 24 days after EDP treatment,
as previously described [18,19].
Experiment 2
Four sows in which pseudopregnancy was induced by a
single administration of 20 mg EDP at 9-13 days after
the onset of estrus (see Results) were used to determine
the changes in the ovaries in relation to circulating hor-
mone profiles after luteolysis. Pseudopregnant sows
were treated with PGF2a as 15 mg dinoprost (Panacelan
Hi; Meiji Seika, Tokyo, Japan) intramuscularly twice at a
24-h interval 24-28 days after EDP treatment. Changes
in ovarian structures, such as follicular growth, ovula-
tion, and regression of CL were monitored daily with
transrectal ultrasonography as previously described [12],
starting 4 days before the first PGF2a treatment and
ending 7 days after the subsequent ovulation. Briefly,
ovaries were scanned with an ultrasound machine (SSD-
900SE; Aloka, Tokyo, Japan) equipped with a 7.5-MHz
linear array transducer. Follicles were identified as anec-
hoic (echo-free) spherical structures and classified by
size as small (≥ 3 and < 6 mm in diameter) or large (≥ 6
mm in diameter). Growth and regression of CL were
expressed in terms of the mean diameter of the largest
CL in each sow on each day. In addition, after sows had
been deemed to be in estrus as defined during 6-h
observations by their first standing response to an intact
boar, the ovaries were scanned at 6-h intervals to detect
the timing of ovulation.
Blood samples were collected every 12 h throughout the
study via an indwelling catheter in the auricular vein and
every 6 h from the first PGF2a treatment to the end of the
subsequent estrus to characterize the hormonal profiles
during the periovulatory period. Plasma was recovered
after centrifugation of blood and stored at -20°C.
Hormone assay
All plasma samples were measured by time-resolved
fluoroimmunoassay (Tr-FIA) for total inhibin, estradiol-
17b, progesterone, LH, and FH concentrations. Concen-
trations of total inhibin were determined by Tr-FIA as
previously described [12]. The intra-assay and interassay
coefficient of variations (CVs) were 10.7% and 15.8%,
respectively. Plasma concentrations of estradiol-17b and
progesterone were measured with a Tr-FIA kit (DELFIA
Estradiol and Progesterone kits; PerkinElmer Japan,
Yokohama, Japan), as previously reported [20]. The
intra-assay and interassay CVs were 8.4% and 10.1% for
estradiol-17b and 7.8% and 7.4% for progesterone,
respectively. Plasma concentrations of LH and FSH were
determined using Tr-FIA methods previously described
by Noguchi et al. [20] and Ohnuma et al. [21], respec-
tively. The intra-assay and interassay CVs were 6.8% and
8.4% for LH and 7.2% and 10.0% for FSH, respectively.
Statistical analyses
The duration of the LH surge was considered to be the
time from the onset to the end of the LH surge, as
defined by a previously described method [22]. Briefly,
t h eo n s e to rt h ee n do fas u r g ew a sd e f i n e da st h ef i r s t
or last LH sample that exceeded the presurge baseline
by twice of standard deviation and did not return to
that baseline within 6 h. Data pertaining to follicular
growth and hormonal profiles were subjected to analysis
of variance (ANOVA) for repeated measures [23]. When
a significant effect was detected by ANOVA, the signifi-
cance of the difference between means was determined
by Tukey’s test. Regression analysis between EDP dosage
and the peak concentration of plasma estradiol-17b,w a s
also performed. All data were analyzed using the GLM
or REG procedure of SAS (SAS Institute, Inc., Cary,
NC). A value of P < 0.05 indicated statistical signifi-
cance. Treatment effects on the incidence of pseudo-
pregnancy were analyzed using c
2 analysis.
Results
Induction of pseudopregnancy with different dosages
and timing of EDP administration
Efficiency of the induction of pseudopregnancy in each
EDP treatment group is shown in Table 1. Of the differ-
ent dosages of EDP administration, the proportion of
pseudopregnant pigs treated with 20 mg was higher
than the proportion of pigs that underwent no treat-
ment (P < 0.05). There was a positive correlation
between EDP dosages and peak plasma concentrations
of estradiol-17b after treatment (r = 0.66, P < 0.05).
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with EDP at 8 or 11 days after ovulation (equivalent to
9-13 days after the onset of estrus) was observed, while
the incidence did not differ significantly with the timing
of EDP treatment. Mean peak concentrations of estra-
diol-17b (130.2 to 309.0 pg/mL) did not differ signifi-
cantly among groups. When EDP was administered at
13 days after ovulation (14-16 days after the onset of
estrus), plasma progesterone concentrations from 12 h
onwards after treatment were lower (P < 0.05) than
those 2 days before treatment. In contrast, there was no
s i g n i f i c a n tc h a n g ei np l a s m ap r o g e s t e r o n el e v e l sf o r3
days before or after EDP treatment in the other groups
(data not shown).
Hormonal profiles during pseudopregnancy
The overall pseudopregnancy rate in pigs treated once
with 20 mg of EDP at 9-13 days after the onset of estrus
was 85.7% (12/14). Of these 12 pseudopregnant pigs,
profiles of total inhibin, estradiol-17b, progesterone, LH,
and FSH in 10 sows are shown in Figure 1. Total inhi-
bin levels in plasma were reduced (P < 0.05) from 1 to
14 days compared with that on the day of EDP treat-
ment, and were increased (P < 0.05) at 16, 18, 19, and
23 days compared with the minimum level at 5 days
after EDP treatment (Figure 1A). Plasma estradiol-17b
concentrations in pseudopregnant sows were higher (P
< 0.05) from 0.5 to 7 days than those before EDP treat-
ment (Figure 1B). Plasma progesterone levels in pseudo-
pregnant sows were maintained at more than 5 ng/mL
throughout the experimental period, while progesterone
concentrations from 7 to 24 days were lower (P <0 . 0 5 )
than on the day of EDP treatment (Figure 1B). While
FSH levels did not change significantly during the study
period, plasma LH concentrations were lower (P < 0.05)
at 2, 6, 7, 15, 17, and 20 days than 3 days before EDP
treatment (Figure 1C).
Exhibition of estrus, ovarian changes, and hormonal
profiles after PGF2a treatment in pseudopregnant pigs
The onset of estrus was detectable in all sows 5.5 ± 0.1
days after the first PGF2a treatment. The mean diameter
of the largest CL was lower (P < 0.05) 4 days after the
first PGF2a treatment than at treatment, and CL were
not identified for the next 4 days (Figure 2A). Formation
of CLs was identically observed at 2 days after ovulation
(9 days after the PGF2a treatment) in all sows, and the
CL diameter markedly increased thereafter. The mean
number of small follicles (≥ 3 and < 6 mm in diameter)
at 3 days after the PGF2a treatment was increased (P <
0.05) compared with the day of the treatment, and then
decreased again (P < 0.05) by 8 days after the treatment
(Figure 2B). Large follicles (≥ 6 mm in diameter) were
not observed between 3 days before and 3 days after the
treatment, but were present at 4 days after treatment
(Figure 2B). The mean numbers of large follicles
Table 1 Efficiency of the induction of pseudopregnancy
with different dosages and timing of EDP treatment
Category No. of pigs No. of pseudopregnancies (%)
Dosage*
0m g 4 0( 0 )
a
10 mg 4 1 (25.0)
ab
20 mg 5 4 (80.0)
b
30 mg 4 3 (75.0)
ab
Timing
†
Day 5 5 3 (60.0)
Day 8 5 4 (80.0)
Day 11 4 4 (100)
Day 13 5 2 (40.0)
*Pigs were treated with each dosage of EDP once at 10-13 days after the
onset of estrus.
†Pigs were treated with 20 mg EDP once at 5, 8, 11 or 13 days after ovulation.
a, bValues with different superscripts within a column in the different dosage
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Figure 1 Profiles of reproductive hormones in pseudopregnant
sows. Changes in the plasma concentrations of total inhibin (A),
estradiol-17b and progesterone (B), and LH and FSH (C) in 10
pseudopregnant sows were indicated. Pseudopregnancy was
induced by a single treatment with 20 mg EDP at 9-13 days after
the onset of estrus. Values are means ± standard error of means
(SEM).
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Page 4 of 7between 5 and 7 days after the treatment were greater
(P < 0.05) than those at 3 days after the treatment. Ovu-
lation was detected in all sows at 7.6 ± 0.2 days after
PGF2a treatment, and the number of ovulated follicles
was 15.5 ± 1.4.
The mean concentration of total inhibin was higher 4
days after PGF2a treatment than that at the treatment
(461.7 ± 10.8 pg/mL vs. 215.8 ± 15.8 pg/mL, P <0 . 0 5 ) ,
and remained higher than 500 pg/mL for the next 2
days (Figure 3A). Total inhibin levels at 7 days after the
treatment were lower than on the previous day (314.0 ±
45.7 pg/mL vs. 522.7 ± 45.0 pg/mL, P < 0.05), after
which they did not change significantly. Concentrations
of estradiol-17b were greater (P < 0.05) at 4 to 6 days
after PGF2a treatment than before the treatment. At 7
days after treatment, estradiol-17b concentrations had
decreased to 1.5 ± 0.2 pg/mL from the maximum value
(27.1 ± 2.1 pg/mL) at 5 days after treatment (Figure 3B).
Plasma progesterone levels decreased markedly (P <
0.05) from 6 h after PGF2a treatment and were at their
minimum between 1 and 8 days after treatment (Figure
3B). An LH surge after PGF2a treatment was observed
in three of four sows, peaking at 6.1 ± 0.2 days after the
treatment (Figure 3C). Concentrations of LH and FSH
increased (P < 0.05) at 6 and 8 days after the treatment,
respectively, compared with those on the day of the
treatment (Figure 3C).
Discussion
The present study indicated that a single treatment with
20 mg of EDP at 9-13 days after the onset of estrus
could induce pseudopregnancy with high efficiency of
80% or more in pigs. This study also revealed that
administration of EDP not only prevented luteolysis in
pigs but also influenced inhibin secretion. However,
treatment with PGF2a in EDP-induced pseudopregnant
pigs appeared to have no detrimental effect on final fol-
licular development and ovulation.
High efficiency of pseudopregnancy (75-80%) was
achieved in pigs treated once with 20 or 30 mg of EDP
at 10-13 days after the onset of estrus, whereas only
25% of pigs treated with 10 mg of EDP became pseudo-
pregnant. These results corresponded with those of a
previous report [24] in which a single injection of 25 to
1 0 0m go fs l o w - r e l e a s i n ge s t r a d i o l - 1 7 b (SRE) incorpo-
rated into poly (D, L-lactide) microspheres, which was
an experimental pharmaceutical preparation, induced
pseudopregnancy in 86% to 88% of pigs, whereas the
pseudopregnancy rate after treatment with 12.5 mg of
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pseudopregnant sows. Changes in the diameter of maximum-
sized corpora lutea (A) and numbers of small and large follicles (B)
after PGF2a treatment in pseudopregnant sows (n = 4) were
indicated. Arrows in each panel indicate treatment with PGF2a.
Estrus (shaded bar) and ovulation (rhombus) are shown at the
bottom of figure. Values are means ± SEM.
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Page 5 of 7SRE was 50%. Administration of a total dose of 20 to 50
mg of EB [2,25] or EV [3] in repeated administrations
between 11 and 15 days of the porcine estrous cycle has
also provided high efficiency of pseudopregnancy.
In the present study, pigs treated with EDP at 8 or 11
days after ovulation (9-13 days after the onset of estrus)
became pseudopregnant with high efficiency (80-100%),
but they did not differ significantly from those treated at
5 or 13 days after ovulation (40-60%). In pregnant pigs,
concentrations of estrogen in the uterine lumen increase
biphasically from 11 to 12 days and after 14 days of
gestation, resulting in the first and second periods of
maternal recognition [1]. The increase of estrogen con-
centrations in vivo, especially in the uterus from 11 to
12 days and 14 days of the estrus cycle, is also impor-
tant for complete establishment of pseudopregnancy in
cyclic pigs [2,25,26]. Plasma estradiol-17b concentrations
in pigs administered EDP at 8 or 11 days after ovulation
remained high for 6-8 days (data not shown). The varia-
tion in pseudopregnancy rates among the different tim-
ing of EDP administration may be influenced by
estrogen levels in the uterus from 11 to 12 days and
after 14 days of the estrous cycle, which correspond to
the levels in plasma.
Our study indicated that plasma inhibin concentra-
tions in pseudopregnant pigs were suppressed from 1
to 14 days after EDP administration. Exogenous estra-
diol induces follicular atresia in monkeys [14]. Expres-
sion of mRNA encoding inhibin a and bA subunits in
atretic follicles was clearly decreased compared with
those in healthy follicles in pigs [27]. Thus, it is sug-
gested that high estradiol-17b concentrations in the
plasma of EDP-treated pigs induce early follicular
atresia, resulting in decreased plasma inhibin
concentrations.
In our ultrasonographic examinations, the mean num-
ber of small follicles (≥ 3 and < 6 mm in diameter)
detected on the day of PGF2a treatment, which ranged
from 24 to 28 days after EDP treatment, was 6.3. This
number was less than half of the number of the same-
sized follicles (15.3) during the luteal phase (8 day
before ovulation) of a normal estrous cycle [12]. In gen-
eral, peripheral LH and FSH levels influence follicular
emergence [28], and high concentrations of estradiol-
17b cause suppression of the peripheral concentrations
of LH in ovariectomized [29], cyclic [15], and pseudo-
pregnant pigs [30]. In the present study, peripheral LH
levels in pseudopregnant pigs were reduced at some
points after EDP treatment, while an effect of EDP on
FSH secretion was not evident in this study. The
reduced number of follicles ≥ 3 mm in diameter 3 to 4
weeks after EDP treatment may have been caused by
delayed follicular emergence in association with suppres-
sion of LH secretion.
Although inhibin secretion was initially suppressed fol-
lowing EDP treatment (approximate range, 100-200 pg/
mL), it appeared to return to normal levels (approximate
range, 200-300 pg/mL) 3-4 weeks later, corresponding to
the baseline levels of the estrous cycle in the previous
report [12]. Thereafter, changes in the number of follicles
≥ 3 mm in diameter and hormonal profiles in pseudo-
pregnant sows from 3 days after PGF2a treatment were
similar to those from the late luteal to the follicular
phase of the estrous cycle in sows [12]. Moreover, the
characteristics of estrus, preovulatory LH surge and ovu-
lation in the PGF2a-treated pseudopregnant sows were
also similar to those in cyclic sows [12,20,31-33] and
pseudopregnant gilts induced by EB [34]. Thus, it is likely
that the estrus synchronization protocol using EDP and
PGF2a has no adverse effect on follicular development
(from 3 mm in diameter) to ovulation.
Conclusions
This study has defined the effective dose and timing of
EDP treatment for inducing pseudopregnancy in cyclic
pigs. Since EDP caused a lowering of inhibin concentra-
tions during pseudopregnancy and small numbers of fol-
licles from 20 to 28 days after EDP, administration of
EDP may affect not only the maintenance of luteal func-
tion, but also follicular atresia and recruitment in the
ovary. However, final follicular development and ovula-
tion following PGF2a administration in the pseudopreg-
nant pigs appear to be similar to those occurring during
the natural estrous cycle. Thus, the use of EDP in com-
bination with PGF2a should simplify and effective the
porcine estrus synchronization protocol for not only
gilts but also sows that had failed to conceive at the first
estrus after weaning.
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